|
|
Article: U.S. Patent Disclosures.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Cellectis SA, of Paris, said the Institut Pasteur was awarded U.S. Patent Nos. 6,528,313 and 6,528,314 related to the homologous recombination process. Cellectis, the patents' licensee, said they cover specific replacement of a copy of a gene present in the recipient genome by the integration of a gene different from that where the integration is made.
Nabi Biopharmaceuticals, of Boca Raton, Fla., was issued U.S. Patent No. 6,537,559 titled "Staphylococcus aureus antigen-containing whole cell vaccine." The patent covers the composition of an S. aureus vaccine, the method of vaccine preparation, immunotherapy and its use as a therapeutic or prophylactic agent.
...